Balyasny Asset Management’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.8M	Buy	2,692,622 +1,929,063	+253%	+$18.4M	0.04%	631
2025 Q4	$9.27M	Sell	763,559 -1,425,717	-65%	-$17.3M	0.02%	1062
2025 Q3	$25.6M	Buy	2,189,276 +1,970,983	+903%	+$23.6M	0.05%	608
2025 Q2	$2.03M	Buy	218,293 +142,424	+188%	+$1.11M	﹤0.01%	1722
2025 Q1	$556K	Sell	75,869 -21,684	-22%	-$167K	﹤0.01%	2240
2024 Q4	$833K	Buy	+97,553	New	+$952K	﹤0.01%	2006
2024 Q1	–	Sell	-89,000	Closed	-$397K	–	2985
2023 Q4	$397K	Buy	89,000 +36,656	+70%	+$108K	﹤0.01%	2043
2023 Q3	$164K	Buy	52,344 +4,062	+8%	+$16.6K	﹤0.01%	2062
2023 Q2	$249K	Buy	48,282 +32,168	+200%	+$191K	﹤0.01%	2039
2023 Q1	$84.9K	Sell	16,114 -8,877	-36%	-$42.2K	﹤0.01%	2332
2022 Q4	$70.2K	Buy	+24,991	New	+$82.7K	﹤0.01%	2300
2022 Q3	–	Sell	-18,459	Closed	-$74K	–	3197
2022 Q2	$74K	Buy	+18,459	New	+$69.7K	﹤0.01%	2317
2022 Q1	–	Sell	-10,912	Closed	-$76K	–	2778
2021 Q4	$76K	Buy	+10,912	New	+$84.7K	﹤0.01%	2007
2021 Q2	–	Sell	-16,704	Closed	-$274K	–	2300
2021 Q1	$274K	Buy	+16,704	New	+$322K	﹤0.01%	1524
2016 Q2	–	Sell	-85,000	Closed	-$821K	–	1399
2016 Q1	$821K	Buy	+85,000	New	+$644K	0.01%	799